Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr;38(2):60-3.
doi: 10.18773/austprescr.2015.018. Epub 2015 Apr 1.

Treatment for Alzheimer's disease: has anything changed?

Louise M Waite  1
Affiliations
Review

Treatment for Alzheimer's disease: has anything changed?

Louise M Waite. Aust Prescr. 2015 Apr.

Abstract

Current therapies for Alzheimer's disease do not modify the course of disease and are not universally beneficial. Clinical trials of drugs targeting amyloid and tau in established Alzheimer's disease have been unsuccessful as it is thought that treating established disease may be too late. Research has moved to the prodromal and pre-symptomatic phases of Alzheimer's disease, with a greater emphasis on the role of biomarkers in defining cases and monitoring response to therapy. Mixed pathologies predominate in the older population. The associations between biomarkers, neuropathology and clinical syndromes are weaker in older people and this is likely to pose a greater challenge in identifying effective therapies.

Keywords: Alzheimer's disease; cholinesterase inhibitors; dementia; memantine.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none declared

References

    1. Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev 2006;(1):CD005593. - PMC - PubMed
    1. McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev 2006;(2):CD003154. - PubMed
    1. Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 2014;311:33-44. - PMC - PubMed
    1. NPS MedicineWise. 2014. Souvenaid: Help for people with Alzheimer’s disease? www.nps.org.au/publications/health-professional/health-news-evidence/201... [cited 2015 Mar 3]
    1. Karran E, Hardy J. Antiamyloid therapy for Alzheimer’s disease--are we on the right road? N Engl J Med 2014;370:377-8. - PubMed